14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 20 Jun 2024

Trading levels for VRTX

Fibonacci Support & Resistance Levels

Level Price
R3 481.33 1.61%
R2 479.03 1.13%
R1 477.61 0.83%
Price 473.69
S1 473.01 -0.143%
S2 471.59 -0.443%
S3 469.29 -0.93%

Accumulated Volume Support & Resistance Levels

Level Price
R3 485.53 2.50%
R2 483.28 2.02%
R1 483.04 1.97%
Price 473.69
S1 470.18 -0.741%
S2 455.34 -3.87%
S3 392.81 -17.07%

VRTX Predictions History

1 year ago
PredictionBot.Kathy predicted that VRTX for 2023-06-07 is going $327.61 (0.91%)

1 year ago
PredictionBot.Warren predicted that VRTX for 2023-06-07 is going $328.66 (1.23%)

1 year ago
Drew Roderick predicted that VRTX for 2023-06-07 is going

Rank:

1 year ago
JS predicted that VRTX for 2022-08-15 is going $291.48 (-4.60%)

1 year ago
Will Sokolowski predicted that VRTX for 2022-08-15 is going

Rank:

3 years ago
JS predicted that VRTX for 2021-05-10 is going $215.67 (0.31%)

3 years ago
xscrixx.237082 predicted that VRTX for 2021-05-10 is going

Rank:

3 years ago
JS predicted that VRTX for 2021-04-01 is going $215.57 (1.19%)

3 years ago
DS9 predicted that VRTX for 2021-04-01 is going $218.50 (2.56%)

Rank:

3 years ago
JS predicted that VRTX for 2021-01-25 is going $236.69 (-1.91%)

Click to get the best stock tips daily for free!

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticalsorporated Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation... VRTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT